Haptoglobin-related protein as a serum marker in malignant lymphoma

Pathology and Oncology Research

Volumn 4, Issue 4, 1998, Pages 271-276

  Epelbaum, Ron ^a   Shalitin, Channa ^b   Segal, Ruth ^a   Valansi, Clari ^b   Arselan, Ida ^c   Faraggi, David ^c   Leviov, Michelle ^a   Ben Shahar, Menahem ^a   Haim, Nissim ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c UNIVERSITY OF HAIFA   (Israel)

Author keywords

21 kDa protein; ELISA; Haptoglobin related protein; Lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; HAPTOGLOBIN; LACTATE DEHYDROGENASE; POLYCLONAL ANTIBODY; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; SERUM;

EID: 0032455280     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02905217     Document Type: Article

References (2)

1. Child JA, Spati B, Illingworth S, et al: Serum beta 2 microglobulin and c-reactive protein in the monitoring of lymphoma. Cancer 45:318-326, 1980.
2. Swan F, Velasquez WS, Tucker S, et al: A new serologic staging system for large-cell lymphomas based on initial 2-microglobulin and lactate dehydrogenase levels. J Clin Oncol 7:1518-1527, 1989.